Joe Biden Administration Delays Mint Cigarette Ban Indefinitely

Regulations by 2FIRSTS.ai
Apr.28.2024
Joe Biden Administration Delays Mint Cigarette Ban Indefinitely
The Biden administration indefinitely postpones the anticipated menthol cigarette ban, angering anti-smoking advocates but potentially avoiding political backlash.

According to the Associated Press on April 27th, the Biden administration has indefinitely postponed the anticipated ban on menthol cigarettes. This decision has angered anti-smoking advocates but may help avoid a political backlash from Black voters in November.

 

In a statement issued on Friday (26th), Biden's top health official did not provide a timeline for the release of the rule, only stating that the government will take more time to consider feedback, including feedback from civil rights organizations.

 

Health and Human Services Secretary Xavier Becerra stated in a declaration, "Clearly, we still have more conversations to have, which will require more time."

 

In recent months, the White House has held dozens of meetings with groups opposed to the ban, including civil rights organizations, law enforcement officials, and small business owners. Many of these groups have financial ties to tobacco companies.

 

The announcement dealt a blow to the Food and Drug Administration (FDA), which had drafted the ban and projected that it would prevent tens of thousands of deaths caused by smoking-related diseases over the course of 40 years. The agency has been working to ban menthol cigarettes for many government terms but has not yet finalized the rules.

 

Yolonda Richardson, of the "Smoke-Free Kids Campaign," stated in an email that "this decision prioritizes politics over lives, especially Black lives." She noted that the ban is supported by organizations such as the National Association for the Advancement of Colored People and the Congressional Black Caucus.

 

Prior to this, the FDA's efforts regarding menthol cigarettes have been hindered by opposition from the tobacco industry or political priorities. As both Biden and former President Donald Trump sought support from African American voters, both the Republican and Democratic parties will carefully examine the potential impact of the ban before the fall elections.

 

The FDA released a draft of the ban in 2022. Officials under the Biden administration had initially planned to finalize the rule in August of last year. By the end of last year, White House officials indicated they would review the measure in March of this year. However, when the deadline passed last month, some anti-smoking groups filed a lawsuit to compel the release of the regulations.

 

FDA spokesperson Jim McKinney stated on Friday (26th) that the agency remains committed to banning menthol cigarettes.

 

We have clearly stated that these product standards have always been a top priority for us.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12
Why Many E-Liquids Today Are "Not Bad, but Not Memorable" – Mylor’s Approach to Experience Design
Why Many E-Liquids Today Are "Not Bad, but Not Memorable" – Mylor’s Approach to Experience Design
From May 8 to 10, 2026, Mylor (Booth E70) will exhibit at The Vaper Expo UK, where it will showcase its systematic experience design solutions for e-liquids. At present, the e-liquid market commonly faces a challenge: many products have “no obvious shortcomings, but lack memorable features.” In response, Mylor has proposed refined solutions across multiple dimensions, including device-adaptive sweetness, progressive cooling sensation, fruit-oriented sourness, and segmented nicotine experience.
May.08
PMI’s ZYN Launches Loyalty Platform in Mexico, Tapping World Cup Viewing Scenes for Nicotine Pouch Marketing
PMI’s ZYN Launches Loyalty Platform in Mexico, Tapping World Cup Viewing Scenes for Nicotine Pouch Marketing
PMI’s nicotine pouch brand ZYN has launched the ZYN Club loyalty platform in Mexico and introduced ZYN Live Stadium viewing experiences around football matches, showing how nicotine pouch brands are using rewards, limited benefits and offline consumption settings to reach adult consumers.
Jun.29
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new regulations on nicotine in Argentina are creating caution, expectations, and doubts about the market, according to a local reference in harm reduction for smoking.
The new Argentine framework for tobacco and nicotine marks a shift from prohibition towards registration, traceability, and health surveillance. Juan Facundo Teme told 2Firsts that adult consumers and some of the commercial sector are cautiously optimistic, although concerns remain about flavors, registration costs, and market access.
May.11
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12